↓ Skip to main content

Cochrane Database of Systematic Reviews

Methotrexate for treating rheumatoid arthritis

Overview of attention for article published in Cochrane database of systematic reviews, June 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
8 X users
wikipedia
4 Wikipedia pages

Citations

dimensions_citation
199 Dimensions

Readers on

mendeley
526 Mendeley
Title
Methotrexate for treating rheumatoid arthritis
Published in
Cochrane database of systematic reviews, June 2014
DOI 10.1002/14651858.cd000957.pub2
Pubmed ID
Authors

Maria Angeles Lopez‐Olivo, Harish R Siddhanamatha, Beverley Shea, Peter Tugwell, George A Wells, Maria E Suarez‐Almazor

Abstract

Methotrexate is a folic acid antagonist widely used for the treatment of neoplastic disorders. Methotrexate inhibits the synthesis of deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins by binding to dihydrofolate reductase. Currently, methotrexate is among the most commonly used drugs for the treatment of rheumatoid arthritis (RA). This is an update of the previous Cochrane systematic review published in 1997.

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 526 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 <1%
Switzerland 1 <1%
Brazil 1 <1%
Pakistan 1 <1%
South Africa 1 <1%
Spain 1 <1%
Unknown 518 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 72 14%
Student > Bachelor 58 11%
Researcher 53 10%
Student > Ph. D. Student 51 10%
Student > Postgraduate 32 6%
Other 97 18%
Unknown 163 31%
Readers by discipline Count As %
Medicine and Dentistry 181 34%
Nursing and Health Professions 30 6%
Pharmacology, Toxicology and Pharmaceutical Science 29 6%
Biochemistry, Genetics and Molecular Biology 23 4%
Agricultural and Biological Sciences 17 3%
Other 66 13%
Unknown 180 34%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2023.
All research outputs
#1,646,158
of 25,806,763 outputs
Outputs from Cochrane database of systematic reviews
#3,488
of 13,140 outputs
Outputs of similar age
#15,749
of 245,112 outputs
Outputs of similar age from Cochrane database of systematic reviews
#65
of 240 outputs
Altmetric has tracked 25,806,763 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 73% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,112 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 240 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.